SCHEDULE: Olesen Value Fund Discloses Solitron Devices Stake

Olesen Value Fund L.P. and associated entities have filed a Schedule 13D, reporting beneficial ownership of 10.1% of Solitron Devices Inc. common stock, acquired for investment purposes.

Summary

• Olesen Value Fund L.P., Olesen Value Fund GP LLC, and Christian Olesen (collectively, the Reporting Persons) have filed an amended Schedule 13D regarding their beneficial ownership of Solitron Devices Inc. common stock.
• The Reporting Persons collectively beneficially own 216,508 shares, representing approximately 10.1% of the Issuer's outstanding shares.
• The shares were acquired by Olesen Value Fund L.P. through open market transactions for an aggregate purchase price of approximately $811,460.
• The purpose of the transaction is for investment, with the Reporting Persons interested in discussing shareholder value creation options with the Issuer's management and board.
• The Reporting Persons may adjust their investment based on ongoing evaluations of market conditions, the Issuer's financial condition, and results.
• Recent transactions within the last 60 days show sales of shares by Olesen Value Fund L.P. on various dates between June 24, 2026, and July 22, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it indicates significant ownership and a desire to engage on shareholder value, the recent sales and the conditional nature of future intentions temper a more positive outlook.

Positives

• Reporting Persons hold a significant stake (10.1%) in Solitron Devices Inc., indicating a belief in the company's potential.
• The Reporting Persons are actively seeking to engage with management to create shareholder value.
• The acquisition of shares was funded through general working capital, suggesting no immediate reliance on debt for the initial investment.

Negatives

• The filing details multiple sales of shares by Olesen Value Fund L.P. within the last 60 days, totaling over 16,000 shares, which could indicate a reduction in their conviction or a need for liquidity.
• The shares are held in margin accounts, which may carry inherent risks and could lead to forced selling under certain market conditions.

Risks

• The Reporting Persons may determine to decrease their investment in the Common Stock through open market, privately negotiated, or any other transactions.
• The shares are held in margin accounts, which may have debit balances and could be subject to margin calls.
• Future intentions regarding the investment are subject to ongoing evaluation of general market conditions and the Issuer's financial condition and results.

Future Outlook

The Reporting Persons may determine to hold, increase, or decrease their investment in the Common Stock based on their ongoing evaluation of general market conditions, the Issuer's financial condition and results, and other relevant factors. Their intentions are subject to change.

Management Comments

• The Reporting Persons are interested in discussing with the Issuer's management, board of directors, and/or with third parties any options relating to shareholder value creation.
• Depending on the Reporting Persons' ongoing evaluation of general market conditions and general matters related to the Issuer, including the Issuer's financial condition and results, the Reporting Persons may determine whether to hold, increase, or decrease their investment in the Common Stock through open market, privately negotiated, or any other transactions.
• Depending on their assessment of the forgoing factors, the Reporting Persons may, from time to time, modify their present intentions as stated in this Item 4.

Industry Context

StockSavvy.ai notes that Schedule 13D filings often signal increased investor engagement or potential activism. The stated intention to discuss shareholder value creation with management suggests Olesen Value Fund may be exploring strategic options for Solitron Devices Inc., a behavior common among institutional investors seeking to influence corporate strategy.

Stakeholder Impact

• Shareholders may benefit from potential discussions aimed at increasing shareholder value.
• Management and the board of directors will likely engage with the Reporting Persons regarding their investment strategy and proposals.

Next Steps

• Reporting Persons may engage in discussions with Solitron Devices Inc. management and board regarding shareholder value creation.
• Reporting Persons may adjust their investment in Solitron Devices Inc. based on market conditions and company performance.

Key Dates

Recommendation

The filing indicates a significant stake and a desire to influence shareholder value, but the recent sales and the conditional nature of future actions suggest a 'hold' position. Investors should monitor further communications and actions from Olesen Value Fund and Solitron Devices Inc. management.

Keywords

Solitron Devices Inc., Schedule 13D, Olesen Value Fund, Beneficial Ownership, Investment, Shareholder Value, Common Stock, Activist Investor